Recommendations for the optimal introduction of novel antibiotics to treat uncomplicated gonorrhoea in the face of increasing antimicrobial resistance: a case study with zoliflodacinFernando Pascual, Angélica Espinosa Miranda, Teri Roberts et al.|BMC Global and Public Health|2024Cited by 12
P-1251. Pharmacometric Analyses to Support Dose Selection of Zoliflodacin, a First-in-Class Oral Antibiotic Being Developed for the Treatment of Uncomplicated GonorrheaSujata M. Bhavnani, Christopher M. Rubino, Anthony P Cammarata et al.|Open Forum Infectious Diseases|2025Cited by 4